National regulations vary significantly across member states

The absence of a unified EU-wide authorization for CBD as a food has led to a highly fragmented regulatory patchwork, with each of the 27 member states adopting its own divergent approach to the legality, labeling, and permissible THC content of CBD products. This divergence creates immense challenges for multinational companies seeking to distribute their products across the bloc, as a product that is entirely legal in one country may constitute a criminal offense in a neighboring state. For example, Switzerland (though not an EU member, it is part of the Schengen area) has adopted a relatively liberal stance, permitting the sale of CBD products with THC content up to 1.0%, which is substantially higher than the EU standard. Conversely, Sweden and Finland maintain an effectively zero-tolerance policy, only permitting products that are certified as entirely free of THC, a standard that is difficult and expensive to achieve in practice given the inevitable trace presence of other cannabinoids in full-spectrum extracts. Germany, the largest market in Europe, has allowed the sale of CBD as a food supplement under certain conditions but has simultaneously issued rulings that classify CBD as a medicinal product when manufacturers make therapeutic claims, creating a blurred boundary that is enforced inconsistently across different federal states. Italy, another major market, has experienced regulatory whiplash, with health ministry decrees alternately tightening and relaxing restrictions on hemp flowers and derivatives, leaving businesses in a state of perpetual uncertainty. Meanwhile, France, historically one of the most restrictive markets, has recently opened up following a landmark court ruling, but retains stringent limits on the parts of the plant that can be used. This Balkanized regulatory environment not only stifles cross-border trade but also creates significant consumer confusion, as citizens traveling between countries cannot reliably assess the legality of the products in their possession.